000 01691 a2200505 4500
005 20250513145616.0
264 0 _c19980810
008 199808s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1998.tb11054.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoulter, N R
245 0 0 _aDifferent vaccine strategies used to protect against Theileria annulata.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cJun 1998
300 _a234-46 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Protozoan
_xblood
650 0 4 _aAntibody Formation
650 0 4 _aAntigens, Protozoan
_ximmunology
650 0 4 _aCattle
650 0 4 _aHepatitis B Core Antigens
_xbiosynthesis
650 0 4 _aISCOMs
650 0 4 _aLymph Nodes
_xparasitology
650 0 4 _aProtozoan Proteins
_xbiosynthesis
650 0 4 _aProtozoan Vaccines
650 0 4 _aRecombinant Fusion Proteins
_xbiosynthesis
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTheileria annulata
_ximmunology
650 0 4 _aTheileriasis
_ximmunology
650 0 4 _aVaccines, Synthetic
700 1 _aBrown, C G
700 1 _aKirvar, E
700 1 _aGlass, E
700 1 _aCampbell, J
700 1 _aMorzaria, S
700 1 _aNene, V
700 1 _aMusoke, A
700 1 _aD'Oliveira, C
700 1 _aGubbels, M J
700 1 _aJongejan, F
700 1 _aHall, F R
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 849
_gp. 234-46
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1998.tb11054.x
_zAvailable from publisher's website
999 _c9634441
_d9634441